Bio-Path Holdings Company Profile (NASDAQ:BPTH)

About Bio-Path Holdings

Bio-Path Holdings logoBio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused antisense drug development company. The Company utilizes a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Its drug delivery and antisense technology, DNAbilize, is a platform that uses P-ethoxy, a deoxyribonucleic acid backbone modification. Its lead drug candidate, Liposomal Grb2 (BP1001), targets the protein Growth factor receptor-bound protein 2 (Grb2). Its other liposome delivered antisense drug candidate, Liposomal Bcl2 (BP1002), targets the protein B-cell lymphoma 2 (Bcl2). BP1001 is in Phase II clinical trials for acute myeloid leukemia, and for blast phase and accelerated phase chronic myelogenous leukemia. BP1002 is intended to target the lymphoma and certain solid tumor markets. BP1001 is also in preclinical studies for solid tumors, including triple negative breast cancer and inflammatory breast cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Delivery
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BPTH
  • CUSIP:
Key Metrics:
  • Previous Close: $1.66
  • 50 Day Moving Average: $1.704
  • 200 Day Moving Average: $2.110
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -33.80
  • P/E Growth: 0.000
  • Market Cap: $161.16M
  • Outstanding Shares: 95,645,000
  • Beta: 1.31
Additional Links:
Companies Related to Bio-Path Holdings:

Analyst Ratings

Consensus Ratings for Bio-Path Holdings (NASDAQ:BPTH) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.50 (107.10% upside)

Analysts' Ratings History for Bio-Path Holdings (NASDAQ:BPTH)
Show:
DateFirmActionRatingPrice TargetDetails
8/11/2016Rodman & RenshawSet Price TargetBuy$5.00View Rating Details
8/10/2016Maxim GroupLower Price TargetBuy$5.00 -> $2.00View Rating Details
(Data available from 8/25/2014 forward)

Earnings

Earnings History for Bio-Path Holdings (NASDAQ:BPTH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016        
8/10/2016Q2($0.02)($0.02)ViewN/AView Earnings Details
5/11/2016Q1($0.01)($0.02)$2.33 millionViewListenView Earnings Details
3/15/2016Q4($0.01)($0.02)ViewN/AView Earnings Details
3/17/2015$0.01($0.02)ViewN/AView Earnings Details
11/18/2014($0.01)($0.01)ViewN/AView Earnings Details
8/18/2014Q214($0.01)($0.01)ViewN/AView Earnings Details
4/2/2014$0.01$0.01ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bio-Path Holdings (NASDAQ:BPTH)
Current Year EPS Consensus Estimate: $-0.05 EPS
Next Year EPS Consensus Estimate: $-0.05 EPS

Dividends

Dividend History for Bio-Path Holdings (NASDAQ:BPTH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Bio-Path Holdings (NASDAQ:BPTH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/13/2015Michael J GarrisonDirectorBuy7,343$1.22$8,958.46View SEC Filing  
7/9/2015Michael J GarrisonDirectorBuy8,724$1.17$10,207.08View SEC Filing  
7/8/2015Michael J GarrisonDirectorBuy60,000$1.19$71,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Bio-Path Holdings (NASDAQ:BPTH)
DateHeadline
News IconLet's Take a Closer Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 23 at 8:06 AM
News IconStock Tracking Lower for the Quarter: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Post News (NASDAQ:BPTH)
www.kentuckypostnews.com - August 21 at 8:38 AM
News IconSmall Cap Insight on Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 20 at 3:56 PM
finance.yahoo.com logoBIO-PATH HOLDINGS INC Financials (NASDAQ:BPTH)
finance.yahoo.com - August 19 at 4:36 PM
News IconPenny Stock Alert - Update & Review on This Stock: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 19 at 12:18 PM
News IconA Closer Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 17 at 12:05 PM
News IconTaking A Closer Look at Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 17 at 12:05 PM
News IconSmall Cap Update on: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Duncan Research (NASDAQ:BPTH)
www.duncanindependent.com - August 15 at 4:03 PM
cnbc.com logoBio-Path reports 2Q loss (NASDAQ:BPTH)
www.cnbc.com - August 10 at 9:24 PM
globenewswire.com logoBio-Path Holdings Reports Second Quarter 2016 Financial Results (NASDAQ:BPTH)
globenewswire.com - August 10 at 9:24 PM
seekingalpha.com logoBio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q2 2016 Results - Earnings Call Transcript (NASDAQ:BPTH)
seekingalpha.com - August 10 at 9:24 PM
seekingalpha.com logoBio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:BPTH)
seekingalpha.com - August 10 at 3:23 PM
biz.yahoo.com logoBIO-PATH HOLDINGS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh (NASDAQ:BPTH)
biz.yahoo.com - August 10 at 3:23 PM
finance.yahoo.com logoBio-Path Holdings to Announce Second Quarter 2016 Financial Results on August 10, 2016 (NASDAQ:BPTH)
finance.yahoo.com - August 3 at 12:39 PM
biz.yahoo.com logoBIO-PATH HOLDINGS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exh (NASDAQ:BPTH)
biz.yahoo.com - August 2 at 8:43 AM
News IconStock Displaying Signs of a Downtrend: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Press Telegraph (NASDAQ:BPTH)
presstelegraph.com - July 23 at 3:53 PM
News IconBio Path Holdings DE (NASDAQ:BPTH) Shorted Shares Increased By 216.62% - Consumer Eagle (NASDAQ:BPTH)
www.consumereagle.com - July 19 at 3:57 PM
kcregister.com logoTop News: Bio-Path Holdings, Inc. (NASDAQ:BPTH), Great Basin Scientific, Inc. (NASDAQ:GBSN), Acasti Pharma Inc ... - KC Register (NASDAQ:BPTH)
www.kcregister.com - July 19 at 10:10 AM
ftsenews.co.uk logoBio-Path Holdings (BPTH) Updated Price Targets - FTSE News (NASDAQ:BPTH)
www.ftsenews.co.uk - July 19 at 10:10 AM
News IconShares Moving Down on the Week: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Engelwood Daily (NASDAQ:BPTH)
www.engelwooddaily.com - July 17 at 3:47 PM
News IconShares Experiencing a Downtrend: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - TGP (NASDAQ:BPTH)
telanaganapress.com - July 16 at 8:28 AM
News IconShare Volatility Watch for: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Engelwood Daily (NASDAQ:BPTH)
www.engelwooddaily.com - July 13 at 12:02 PM
News IconBio-path Holdings Inc (NASDAQ:BPTH) Sentiment Change Report - Consumer Eagle (NASDAQ:BPTH)
www.consumereagle.com - July 13 at 12:02 PM
finance.yahoo.com logoBio-Path Holdings to Present at the 2nd Annual Cantor Fitzgerald Healthcare Conference (NASDAQ:BPTH)
finance.yahoo.com - July 6 at 8:00 AM
bizjournals.com logoHouston biotech firm collaborates with university on brain cancer therapy (NASDAQ:BPTH)
www.bizjournals.com - July 5 at 3:57 PM
News IconCompany Stock Lower on the Week Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Engelwood Daily (NASDAQ:BPTH)
www.engelwooddaily.com - July 2 at 3:57 PM
biz.yahoo.com logoBIO-PATH HOLDINGS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:BPTH)
biz.yahoo.com - July 1 at 6:05 AM
biz.yahoo.com logoBIO-PATH HOLDINGS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stateme (NASDAQ:BPTH)
biz.yahoo.com - June 30 at 6:10 AM
4-traders.com logoBio Path : Announces Collaboration With Thomas Jefferson University for Systemic Antisense Immunotherapy Treatment for Brain Cancer (NASDAQ:BPTH)
www.4-traders.com - June 29 at 8:59 PM
News IconStock Tracking Lower in Session: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Telanagana Press (NASDAQ:BPTH)
telanaganapress.com - June 29 at 3:53 PM
streetinsider.com logoBio-Path Holdings (BPTH) Enters $10M Stock, Warrants Registered Direct Offering - StreetInsider.com (NASDAQ:BPTH)
www.streetinsider.com - June 29 at 3:53 PM
feeds.reuters.com logoBRIEF-Bio Path Holdings announces $10 million registered direct offering (NASDAQ:BPTH)
feeds.reuters.com - June 29 at 12:39 PM
finance.yahoo.com logoBio-Path Holdings, Inc. Announces $10 Million Registered Direct Offering (NASDAQ:BPTH)
finance.yahoo.com - June 29 at 11:59 AM
streetinsider.com logoBio-Path Holdings (BPTH) Enters Brain Cancer Treatment Collaboration with TJU - StreetInsider.com (NASDAQ:BPTH)
www.streetinsider.com - June 28 at 8:24 AM
finance.yahoo.com logo8:02 am Bio-Path enters into a sponsored research agreement with Thomas Jefferson University to investigate DNAbilize (NASDAQ:BPTH)
finance.yahoo.com - June 28 at 8:02 AM
finance.yahoo.com logoBio-Path Holdings Announces Collaboration With Thomas Jefferson University for Systemic Antisense Immunotherapy Treatment for Brain Cancer (NASDAQ:BPTH)
finance.yahoo.com - June 28 at 8:00 AM
News IconStock Volatility in Review: Bio-Path Holdings, Inc. (NASDAQ:BPTH) - Engelwood Daily (NASDAQ:BPTH)
www.engelwooddaily.com - June 27 at 3:36 PM
News IconBio-Path Holdings Inc. (NASDAQ: BPTH) Joins The Russell 3000 Index - Scibility Media (NASDAQ:BPTH)
scibilitymedia.com - June 27 at 3:36 PM
ftsenews.co.uk logoNew Broker Ratings For Bio-Path Holdings (BPTH) - FTSE News (NASDAQ:BPTH)
www.ftsenews.co.uk - June 27 at 8:35 AM
News IconHC Stocks to Path: Athersys, Inc. (NASDAQ:ATHX), Bio-Path Holdings Inc (NASDAQ:BPTH) - share market updates (press release) (NASDAQ:BPTH)
sharemarketupdates.com - June 27 at 8:35 AM
equities.com logoBio-Path Holdings Inc. (BPTH) is Trading Lower on Unusual Volume for June 22 - Equities.com (NASDAQ:BPTH)
www.equities.com - June 24 at 6:34 AM
equities.com logoBio-Path Holdings Inc. (BPTH) Jumps 10.1% on June 21 - Equities.com (NASDAQ:BPTH)
www.equities.com - June 23 at 11:58 AM
equities.com logoBio-Path Holdings Inc. (BPTH) is Trading Higher on Unusual Volume for June 21 - Equities.com (NASDAQ:BPTH)
www.equities.com - June 23 at 11:58 AM
finance.yahoo.com logoBio-Path Holdings to Join Russell 3000® and Global Indexes (NASDAQ:BPTH)
finance.yahoo.com - June 20 at 4:01 PM
fiscalstandard.com logoThis Weeks Broker Views For Bio-Path Holdings (BPTH) - Fiscal Standard (NASDAQ:BPTH)
www.fiscalstandard.com - June 19 at 3:47 PM
equities.com logoBio-Path Holdings Inc. (BPTH) is Trading Lower on Unusual Volume for June 14 - Equities.com (NASDAQ:BPTH)
www.equities.com - June 16 at 8:19 AM
equities.com logoBio-Path Holdings Inc. (BPTH) Drops 8.07% on June 14 - Equities.com (NASDAQ:BPTH)
www.equities.com - June 16 at 8:19 AM
equities.com logoBio-Path Holdings Inc. (BPTH) Drops 8.23% on June 13 - Equities.com (NASDAQ:BPTH)
www.equities.com - June 15 at 8:45 AM
kcregister.com logoAlcoa Inc. (NYSE:AA) decreased -1.79%: ConocoPhillips (NYSE:COP), Bio-Path Holdings, Inc. (NASDAQ:BPTH ... - KC Register (NASDAQ:BPTH)
www.kcregister.com - June 14 at 9:08 AM
equities.com logoBio-Path Holdings Inc. (BPTH) Drops 5.06% on June 07 - Equities.com (NASDAQ:BPTH)
www.equities.com - June 8 at 10:21 PM

Social

Bio-Path Holdings (NASDAQ:BPTH) Chart for Thursday, August, 25, 2016


Last Updated on 8/25/2016 by MarketBeat.com Staff